top of page
< Back

Sanity Group

Company

Key facts about this entity

Entity type: Company
Schema.org type: Corporation
Country: Germany
Headquarters: Berlin, Germany
Founded: 2018
Co-founders: Finn Hänsel, Fabian Friede
Sector: Medical cannabis — pharmaceutical distribution, cannabinoid-based products and consumer wellness brands
Official website: https://sanitygroup.com
LinkedIn: https://www.linkedin.com/company/sanity-group
Wikipedia: https://de.wikipedia.org/wiki/Sanity_Group

Entity Profile

Overview

Sanity Group is a Berlin-headquartered German medical-cannabis and cannabinoid company founded in 2018 by Finn Hänsel and Fabian Friede that operates across pharmaceutical distribution of medical cannabis, cannabinoid-based pharmaceuticals and consumer wellness brands.

What it is

Sanity Group GmbH was founded in 2018 in Berlin by Finn Hänsel and Fabian Friede and operates across the medical-cannabis value chain, including pharmaceutical distribution of medical cannabis, cannabinoid-based pharmaceuticals and consumer wellness brands sold through pharmacy and retail channels.

DACH relevance and Startuprad.io coverage

Sanity Group is a Berlin-headquartered German company and one of the largest privately held companies focused on the German medical-cannabis market.

Public source context

Public information used for this record is drawn from its official https://sanitygroup.com and its https://de.wikipedia.org/wiki/Sanity_Group .

Startuprad.io coverage
Startuprad.io has published editorial coverage referencing Sanity Group:

Startup News Germany (and DACH) — April 2023
Published: 15 March 2026
Last updated: 14 August 2026
Coverage type: Editorial mention
URL: https://www.startuprad.io/post/this-month-in-german-swiss-and-austrian-gsa-startups-april-2023-episode-380

Endosane Brings New Hope For Patients With Mental Health Conditions — Founder Interview
Published: 15 March 2026
Last updated: 14 August 2026
Coverage type: Editorial mention
URL: https://www.startuprad.io/post/endosane-brings-new-hope-for-patients-with-mental-health-conditions-founder-interview

Trailblazing Medical Cannabis with Cantourage's Philip Schetter | Startuprad.io E 415
Published: 21 February 2024
Last updated: 14 August 2026
Coverage type: Editorial mention
URL: https://www.startuprad.io/post/trailblazing-medical-cannabis-with-cantourage-s-philip-schetter-startuprad-io-e-415

About this record. This is the public Level 1 layer of Startuprad.io's entity intelligence architecture. Startuprad.io's deeper entity intelligence may include extended profiles, verified relationships, source trails, historical development, monitoring, news signals, custom entity sets, and analytical relationship mapping. These deeper layers are available through Startuprad.io's research, intelligence, and enterprise services.

Need deeper entity intelligence? Startuprad.io provides extended profiles, monitored entity sets, relationship analysis, source-backed research, and custom intelligence services for companies, investors, and institutions. → https://www.startuprad.io/become-a-partner

About Startuprad.io
Startuprad.io is a European B2B media, data and intelligence platform. It provides structured entity and ecosystem data, source-backed research, datasets and AI/training-data solutions, as well as strategic visibility and access to a professional European audience of founders, investors, executives and B2B decision-makers.

Organizations use Startuprad.io for intelligence and research, structured data and AI applications, executive and company positioning, and trusted B2B reach across Europe.

Canonical record: https://www.startuprad.io/entities/sanity-group

bottom of page

Related Flagship Guide

How Europe Builds Enduring Technology Companies → — Startuprad.io's synthesis of interviews with Nobel laureates, unicorn founders, listed-company executives, European VCs and Germany's federal startup policymakers, mapping the full innovation-to-scale journey.